Drug Delivery Final

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/458

encourage image

There's no tags or description

Looks like no tags are added yet.

459 Terms

1
New cards

USP purpose

Establishes official standards for drug substances dosage forms and compounded preparations; ensures identity strength quality purity consistency.

2
New cards

NF purpose

Establishes standards for pharmaceutical excipients and inactive ingredients used in formulations.

3
New cards

Pharmaceutical dosage forms purpose

Protect from oxygen humidity gastric acid; mask taste odor; control release; enable topical inhalation rectal parenteral delivery; allow bloodstream access; improve swallowing.

4
New cards

External routes of administration

Oral sublingual buccal rectal.

5
New cards

Parenteral routes of administration

Injection nasal vaginal ophthalmic dermal topical transdermal inhalation.

6
New cards

Dosage form classifications

Solid tablets capsules powders; semisolid creams ointments gels; liquids syrups emulsions suspensions; gaseous inhalers nebulizers; specialized patches inserts implants.

7
New cards

Powders and granules

Fast action; more stable than liquids.

8
New cards

Regular tablets

Portable; ease of use.

9
New cards

Coated tablets

Taste and odor masking; easier swallowing.

10
New cards

Enteric coated tablets

Protect acid sensitive drugs.

11
New cards

Chewable tablets

Useful for swallowing difficulty; large drug loads.

12
New cards

Effervescent tablets

Rapid dissolution with CO2; faster onset.

13
New cards

Gummies

Improve compliance swallowing difficulty.

14
New cards

Sustained release tablets

Long acting therapy.

15
New cards

Lozenges

Dissolve slowly in mouth; avoid first pass metabolism.

16
New cards

Pastilles troches

Soft lozenges; slow dissolution.

17
New cards

Medicated gums

Buccal absorption; avoid first pass metabolism.

18
New cards

Fast disintegrating tablets and films

Dissolve rapidly; no water needed.

19
New cards

Sublingual dosage forms

Fast onset; avoid first pass metabolism.

20
New cards

Buccal dosage forms

Fast onset; avoid first pass metabolism.

21
New cards

Caplets

Tablet shaped like capsule; easier swallowing.

22
New cards

Hard gelatin capsules

Mask taste; faster action than tablets.

23
New cards

Sustained release capsules

Coated pellets; prolonged drug release.

24
New cards

Suppositories

Rectal vaginal urethral use; targeted delivery; non oral option.

25
New cards

Monophasic liquid dosage forms

Solutions syrups elixirs tinctures drops.

26
New cards

Biphasic liquid dosage forms

Suspensions solid liquid; emulsions liquid liquid.

27
New cards

Onset of action definition

Time required for drug to produce desired effect.

28
New cards

Onset of action ranking

IV

29
New cards

Biopharmaceutical considerations

Factors affecting absorption by route.

30
New cards

Drug factors in formulation

Physical and chemical properties.

31
New cards

Therapeutic considerations

Clinical indication and patient factors.

32
New cards

Plasticizers excipients

Provide elasticity and flexibility; examples castor oil PEG.

33
New cards

Binders excipients

Improve granule cohesion and flow; examples acacia PVP gelatin.

34
New cards

Disintegrants excipients

Draw water cause swelling and breakup; example starch.

35
New cards

Colorants excipients

Improve aesthetic appearance; FD and C dyes.

36
New cards

Physical drug excipient interactions

Complexation cyclodextrins; adsorption indomethacin; solid dispersions piroxicam norfloxacin ibuprofen.

37
New cards

Chemical drug excipient interactions

Reactions with excipients impurities residues.

38
New cards

Biopharmaceutical interactions

Observed after dosage form administration.

39
New cards

Preformulation physical parameters

Color odor taste particle size surface area flow density compressibility crystallinity hygroscopicity polymorphism.

40
New cards

Preformulation solubility parameters

Solubility ionization constant solubilization thermal effect common ion effect dissolution.

41
New cards

Preformulation stability parameters

Solid state stability solution stability drug excipient compatibility.

42
New cards

Preformulation chemical parameters

Hydrolysis oxidation photolysis chirality.

43
New cards

Hygroscopic substances

Absorb atmospheric moisture; affect stability.

44
New cards

Deliquescent substances

Absorb moisture liquefy leave water film.

45
New cards

Crystalline solids

Ordered molecular lattice.

46
New cards

Amorphous solids

No long range order; higher energy; higher aqueous solubility.

47
New cards

Drug concentration quantity per quantity

g per L mg per mL mg per volume.

48
New cards

Drug concentration percentage

% w v % w w % v v.

49
New cards

Drug concentration parts

Parts by weight of solids per parts by volume.

50
New cards

Drug concentration molarity

Mol per liter.

51
New cards

Drug concentration molality

Mol per kilogram.

52
New cards

Drug concentration mole fraction

Unitless.

53
New cards

Solubility enhancement chemical methods

Salt formation; prodrug formation.

54
New cards

Solubility enhancement physical methods

Particle size reduction cogrinding lipid formulations solubilization complexation carriers solid modification solid dispersion.

55
New cards

Noyes Whitney equation

dm dt = A D over h (Cs − Cb).

56
New cards

Factors increasing dissolution rate

Increased surface area; decreased particle size.

57
New cards

Dissolution rate ranking

Solution > suspension > capsule > tablet > coated tablet.

58
New cards

BCS Class I

High solubility high permeability; propranolol verapamil metoprolol.

59
New cards

BCS Class II

Low solubility high permeability; ketoprofen naproxen carbamazepine.

60
New cards

BCS Class III

High solubility low permeability; ranitidine cimetidine atenolol vancomycin.

61
New cards

BCS Class IV

Low solubility low permeability; furosemide hydrochlorothiazide.

62
New cards

Lipinski rule’s

molecular weight - ≤500 daltons.

H bond donors - ≤5.

H bond acceptors - ≤10.

logP - ≤5.

why we use it - a medicinal chemistry guideline that predicts whether a small molecule will have poor oral absorption and membrane permeability

  • can only deviate from one more than one it should not be used for oral


63
New cards

Lipinski rule exceptions

Transporter substrates antibiotics antifungals vitamins cardiac glycosides; applies to unionized drugs only.

64
New cards

Dry mixture oral solutions

Reconstituted with purified water; stable 7-14 days.

65
New cards

Extemporaneous oral solutions

Pediatric forms from adult products.

66
New cards

Oral rehydration solutions

Treat 5-10% dehydration; OTC.

67
New cards

Oral colonic lavage solution

Bowel prep; 4 L total; 240 mL every 10 min.

68
New cards

Magnesium citrate oral solution

Saline laxative; effervescent clear solution.

69
New cards

Sodium citrate citric acid solution

Systemic alkalinizer; maintains alkaline urine.

70
New cards

Purified water USP

Used for non parenteral preparations.

71
New cards

Water for injection USP

Sterile pyrogen free; used for parenterals.

72
New cards

Syrup definition

Concentrated aqueous sugar or sugar substitute solution.

73
New cards

Syrup NF

Eighty five percent w v sucrose; no flavor.

74
New cards

ORA Sweet syrups

Flavored vehicles; sugar free version available.

75
New cards

Sorbitol solution USP

Sweet bland syrup; pH 5-7.5; contains D sorbitol.

76
New cards

Elixir definition

Sweetened hydroalcoholic oral solution.

77
New cards

Phenobarbital elixir

Official elixir; 14% alcohol.

78
New cards

Theophylline elixir

20% alcohol.

79
New cards

Dexamethasone elixir

5% alcohol.

80
New cards

Digoxin elixir

Pediatric formulation; 10% alcohol.

81
New cards

Vintage elixir

38-40% alcohol; no longer marketed.

82
New cards

Syrups characteristics

Aqueous sweeter higher viscosity less stable better taste masking.

83
New cards

Elixirs characteristics

Hydroalcoholic less sweet lower viscosity more stable easier formulation.

84
New cards

Elixir preservative rule

Not required if alcohol >12% v v.

85
New cards

TDDS first order systems

Target organs tissues capillary beds.

86
New cards

TDDS second order systems

Target specific cell types.

87
New cards

TDDS third order systems

Target intracellular locations.

88
New cards

TDDS carrier classifications

Soluble macromolecules and particulate carriers.

89
New cards

TDDS active moiety

Purpose therapeutic effect.

90
New cards

TDDS carrier system

Purpose distribution protection reduced clearance.

91
New cards

TDDS homing device

Purpose cell or tissue targeting; not needed for passive targeting.

92
New cards

Liposome definition

Spherical vesicles with phospholipid bilayers.

93
New cards

Liposome phospholipids

Amphiphilic bilayer structure.

94
New cards

Liposome sterols

Modify fluidity permeability stability.

95
New cards

Liposome PEG

Prolong circulation; reduce metabolism.

96
New cards

Liposome charged lipids

Enable encapsulation and intracellular delivery.

97
New cards

Small unilamellar vesicles

20-100 nm; single bilayer.

98
New cards

Large unilamellar vesicles

100-1000 nm; single bilayer.

99
New cards

Giant unilamellar vesicles

≥1 µm; single bilayer.

100
New cards

Large multilamellar vesicles

200 nm-3 µm; multiple layers.